Professor
Divisions of Hematology and Computational Biology, Mayo Clinic
Rochester, Minnesota, United States
Susan Slager, Ph.D., is an international leader in the genetic epidemiology of chronic lymphocytic leukemia (CLL), and its precursor condition, monoclonal B-cell lymphocytosis (MBL). Through her leadership and collaborative efforts, her team has identified the majority of inherited variants for risk of CLL and shown that a combined score of these inherited variants is a strong and validated risk factor for risk of CLL. Moreover, her work has also improved the understanding of the clinical consequences of MBL, a common condition affecting 8-10 million individuals, establishing that it is not only a precursor to CLL but also a risk factor for other lymphoid cancers, non-hematological malignancies, and serious infections.
Dr. Slager is a consultant within the Divisions of Hematology and Computational Biology at Mayo Clinic. She is a professor of Biostatistics and recipient of endowed professorship in lymphoma research. Dr. Slager has led 10 NIH funded grants, is a frequent presenter, has authored over 375 peer-reviewed articles in prominent peer-reviewed journals, and has an H-index of 103. She has served on multiple committees for professional organizations and on NIH study sections.
Insights into Pathogenesis From Germline Predisposition/Familial CLL Studies, Including MBL
Saturday, September 13, 2025
08:40 - 08:55 CEST
